专利 已放弃

A PERCUTANEOUS ABSORPTION COMPOSITION

Overview

「A PERCUTANEOUS ABSORPTION COMPOSITION」对应一条老挝专利公开记录,由 MEDRX CO., LTD 于 2016-08-29 提交申请,当前状态为已放弃。关键编号与类型标注为 申请号 P/576 / DIP 编号 LAP576 / 主管局代码 LA / 保护类型 Patent - PCT National Phase。时间线要点:公开/公告日 2026-01-23。国际分类 / IPC 标注为 A61K 31/485、A61K 47/12、A61K 9/70、A61P 25/04。发明人 / 设计人包括 AKAZAWA Naoya、HAMAMOTO Hidetoshi、MIWA Yasushi。代理机构 / 代理人记载为 Lao Trademark Agency (LAO IP AGENCY)。公开摘要提示:An object of the present invention is to provide: a percutaneous absorption composition having an improved skin permeability of a basic med…。

专利 老挝 DIP

申请号 P/576
申请日期 2016-08-29
申请人 MEDRX CO., LTD
代理机构 Lao Trademark Agency (LAO IP AGENCY)
类别 A61K 31/485 · A61K 47/12 · A61K 9/70 · A61P 25/04

图样

下载

基础信息

类型
专利
申请号
P/576
状态
已放弃
申请人
MEDRX CO., LTD
代理机构
Lao Trademark Agency (LAO IP AGENCY)
申请日期
2016-08-29
公开/公告日
2026-01-23
国际分类
A61K 31/485 · A61K 47/12 · A61K 9/70 · A61P 25/04
商品 / 服务

办理流程

根据当前状态动态标注
  1. 提交申请
  2. 形式审查 进行中
  3. 实质审查
  4. 公开
  5. 授权

关联分析

LaoBiz 企业数据库联动

摘要

An object of the present invention is to provide: a percutaneous absorption composition having an improved skin permeability of a basic medicament and an agent for promoting the transdermal absorbability of a basic medicament.

The object can be achieved by the use of a percutaneous absorption composition comprising a basic medicament or a salt thereof and sorbic acid and/or its metal salt.

The concentration of the sorbate component is preferably from 0.5 mole to 2.5 moles per mole of the basic medicament.

Preferably, the composition of the present invention may further comprise an organic basic compound and/or an inorganic basic component.

An object of the present invention is to provide: a percutaneous absorption composition having an improved skin permeability of a basic medicament and an agent for promoting the transdermal absorbability of a basic medicament.

The object can be achieved by the use of a percutaneous absorption composition comprising a basic medicament or a salt thereof and sorbic acid and/or its metal salt.

The concentration of the sorbate component is preferably from 0.5 mole to 2.5 moles per mole of the basic medicament.

Preferably, the composition of the present invention may further comprise an organic basic compound and/or an inorganic basic component.

提交咨询

留下联系方式,顾问将在工作时间内回复。

联系方式 * 点选后填写 · 至少一种
验证码 *
验证码

登录 LaoBiz

使用注册邮箱登录您的账号

或使用

使用 Google 登录

还没有账号?

或使用

使用 Google 注册

已有账号?

该社交账号未提供邮箱,请填写常用邮箱并完成验证后即可登录。